👉 “Is Your Xanax Affected?”
Details On The Nationwide Xanax Recall
Viatris Inc. is voluntarily recalling a specific lot of extended-release Xanax (alprazolam) tablets due to the drug failing to meet dissolution specifications.
Failure to meet dissolution specifications may affect the dosage delivery over time, compromise batch consistency, or impact the absorption rate of the active ingredient into the bloodstream.
Alprazolam is one of the most commonly prescribed benzodiazepines in the United States.
The recall affects one lot of 3 mg Xanax tablets provided in 60-tablet bottles, with the lot number 8177156 and expiration date 02/28/2027.
The recall is classified as Class II by the FDA, indicating that use or exposure to the product may cause temporary or medically reversible adverse health consequences.